Enterococcus faecalis enhances cell proliferation through hydrogen peroxide-mediated epidermal growth factor receptor activation

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3545-3558

  Boonanantanasarn, Kanitsak ^a,b,d   Gill, Ann Lindley ^a   Yap, YoonSing ^b   Jayaprakash, Vijayvel ^e   Sullivan, Maureen A ^e   Gill, Steven R ^a,b,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; HYDROGEN PEROXIDE; KI 67 ANTIGEN; RNA 16S;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROCOCCUS FAECALIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

CELL LINE, TUMOR; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENTEROCOCCUS FAECALIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84867584659     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00479-12     Document Type: Article

References (76)

1. Agrawal N, et al. 2011. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333: 1154-1157.
2. Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS. 2008. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J. Gastroenterol. Hepatol. 23: 1298-1303.
3. Balish E, Warner T. 2002. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 160:2253-2257.
4. Berasain C, et al. 2009. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp. Biol. Med. (Maywood) 234: 713-725.
5. Beswick EJ, Reyes VE. 2008. Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor. Infect. Immun. 76:3233-3240.
6. Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D. 2005. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289:G571-G578.
7. Bruzzese F, et al. 2011. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT. J. Cell. Physiol. 226:2378-2390.
8. Bullwinkel J, et al. 2006. Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J. Cell. Physiol. 206:624-635.
9. Cadenas E, Davies KJ. 2000. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29:222-230.
10. Chang AH, Parsonnet J. 2010. Role of bacteria in oncogenesis. Clin. Microbiol. Rev. 23:837-857.
11. Chavez V, Mohri-Shiomi A, Maadani A, Vega LA, Garsin DA. 2007. Oxidative stress enzymes are required for DAF-16-mediated immunity due to generation of reactive oxygen species by Caenorhabditis elegans. Genetics 176:1567-1577.
12. Chen L, et al. 2011. Identification of hydrogen peroxide productionrelated genes in Streptococcus sanguinis and their functional relationship with pyruvate oxidase. Microbiology 157:13-20.
13. Choi S, Myers JN. 2008. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J. Dent. Res. 87:14-32.
14. Cogulu D, Uzel A, Oncag O, Aksoy SC, Eronat C. 2007. Detection of Enterococcus faecalis in necrotic teeth root canals by culture and polymerase chain reaction methods. Eur. J. Dent. 1:216-221.
15. De Luca A, et al. 2008. The role of the EGFR signaling in tumor microenvironment. J. Cell. Physiol. 214:559-567.
16. DeYulia GJ, Jr, Carcamo JM. 2005. EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases. Biochem. Biophys. Res. Commun. 334: 38-42.
17. Forastiere AA, Burtness BA. 2007. Epidermal growth factor receptor inhibition in head and neck cancer-more insights, but more questions. J. Clin. Oncol. 25:2152-2155.
18. Forsyth CB, et al. 2007. Regulation of oxidant-induced intestinal permeability by metalloprotease-dependent epidermal growth factor receptor signaling. J. Pharmacol. Exp. Ther. 321:84-97.
19. Galcheva-Gargova Z, et al. 1996. Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Science 272:1797-1802.
20. Gokul S, Patil VS, Jailkhani R, Hallikeri K, Kattappagari KK. 2010. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis. 16:29-33.
21. Goldkorn T, et al. 1998. EGF-receptor phosphorylation and signaling are targeted by H2O2 redox stress. Am. J. Respir. Cell Mol. Biol. 19:786-798.
22. Gong M, et al. 2008. p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR. Mol. Cancer Ther. 7:530-537.
23. Han Z, et al. 2008. Aryl hydrocarbon receptor mediates laminar fluid shear stress-induced CYP1A1 activation and cell cycle arrest in vascular endothelial cells. Cardiovasc. Res. 77:809-818.
24. Hashibe M, et al. 2009. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol. Biomarkers Prev. 18:541-550.
25. Holsinger FC, et al. 2003. Epidermal growth factor receptor blockade potentiates apoptosis mediated by paclitaxel and leads to prolonged survival in a murine model of oral cancer. Clin. Cancer Res. 9:3183-3189.
26. Hooper SJ, et al. 2007. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J. Med. Microbiol. 56:1651-1659.
27. Hooper SJ, et al. 2006. Viable bacteria present within oral squamous cell carcinoma tissue. J. Clin. Microbiol. 44:1719-1725.
28. Hooper SJ, Wilson MJ, Crean SJ. 2009. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck 31:1228-1239.
29. Huang RP, et al. 2001. Hydrogen peroxide promotes transformation of rat liver non-neoplastic epithelial cells through activation of epidermal growth factor receptor. Mol. Carcinog. 30:209-217.
30. Huycke MM, Abrams V, Moore DR. 2002. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23:529-536.
31. Huycke MM, Joyce W, Wack MF. 1996. Augmented production of extracellular superoxide by blood isolates of Enterococcus faecalis. J. Infect. Dis. 173:743-746.
32. Jemal A, et al. 2011. Global cancer statistics. CA Cancer J. Clin. 61:69-90.
33. Jepsen SA, Closmann JJ. 2008. The insidious nature and presentation of oral squamous cell carcinoma in the low-risk population. Gen. Dent. 56: 78-82.
34. Joh T, et al. 2005. Helicobacter pylori-stimulated interleukin-8 (IL-8) promotes cell proliferation through transactivation of epidermal growth factor receptor (EGFR) by disintegrin and metalloproteinase (ADAM) activation. Dig. Dis. Sci. 50:2081-2089.
35. Joyce JA. 2005. Therapeutic targeting of the tumor microenvironment. Cancer Cell 7:513-520.
36. Kalyankrishna S, Grandis JR. 2006. Epidermal growth factor receptor biology in head and neck cancer. J. Clin. Oncol. 24:2666-2672.
37. Keates S, Keates AC, Katchar K, Peek RM, Jr, Kelly CP. 2007. Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J. Infect. Dis. 196:95-103.
38. Khan EM, et al. 2006. Epidermal growth factor receptor exposed to oxidative stress undergoes Src-and caveolin-1-dependent perinuclear trafficking. J. Biol. Chem. 281:14486-14493.
39. Khatami M. 2009. Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity: a common denominator mapping chronic diseases. Cell Biochem. Biophys. 55:55-79.
40. Khatami M. 2012. Unresolved inflammation and cancer: loss of natural immune surveillance as the correct 'target' for therapy! Seeing the 'elephant' in the light of logic. Cell Biochem. Biophys. 62:501-509.
41. Kostic AD, et al. 2012. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22:292-298.
42. Lee E, Yi JY, Chung E, Son Y. 2010. Transforming growth factor beta(1) transactivates EGFR via an H(2)O(2)-dependent mechanism in squamous carcinoma cell line. Cancer Lett. 290:43-48.
43. Lee SH, et al. 2009. Arachidonic acid release by H2O2 mediated proliferation of mouse embryonic stem cells: involvement of Ca2 /PKC and MAPKs-induced EGFR transactivation. J. Cell Biochem. 106:787-797.
44. Liu LZ, et al. 2006. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic. Biol. Med. 41:1521-1533.
45. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya KA. 2003. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol. 39:106-114.
46. Luppi F, Longo AM, de Boer WI, Rabe KF, Hiemstra PS. 2007. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 56:25-33.
47. Maehata Y, et al. 2010. Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells. Free Radic. Res. 44:913-924.
48. Mager DL. 2006. Bacteria and cancer: cause, coincidence or cure? A review. J. Transl. Med. 4:14.
49. Mager DL, et al. 2005. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J. Transl. Med. 3:27.
50. Narikiyo M, et al. 2004. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 95:569-574.
51. Nishimura Y, Yoshioka K, Bereczky B, Itoh K. 2008. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line. Mol. Cancer 7:42.
52. Ohno Y, Gallin JI. 1985. Diffusion of extracellular hydrogen peroxide into intracellular compartments of human neutrophils. Studies utilizing the inactivation of myeloperoxidase by hydrogen peroxide and azide. J. Biol. Chem. 260:8438-8446.
53. Oliveira LR, Ribeiro-Silva A. 2011. Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int. J. Oral Maxillofac. Surg. 40:298-307.
54. Pan Q, Qiu WY, Huo YN, Yao YF, Lou MF. 2011. Low levels of hydrogen peroxide stimulate corneal epithelial cell adhesion, migration, and wound healing. Invest. Ophthalmol. Vis. Sci. 52:1723-1734.
55. Parkin DM, Laara E, Muir CS. 1988. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer 41:184-197.
56. Pillar CM, Gilmore MS. 2004. Enterococcal virulence-pathogenicity island of E. faecalis. Front. Biosci. 9:2335-2346.
57. Polytarchou C, Hatziapostolou M, Papadimitriou E. 2005. Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J. Biol. Chem. 280:40428-40435.
58. Purdom S, Chen QM. 2005. Epidermal growth factor receptordependent and-independent pathways in hydrogen peroxide-induced mitogen-activated protein kinase activation in cardiomyocytes and heart fibroblasts. J. Pharmacol. Exp. Ther. 312:1179-1186.
59. Ravid T, Sweeney C, Gee P, Carraway KL, 3rd, Goldkorn T. 2002. Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J. Biol. Chem. 277:31214-31219.
60. Reuter CW, Morgan MA, Eckardt A. 2007. Targeting EGF-receptorsignalling in squamous cell carcinomas of the head and neck. Br. J. Cancer 96:408-416.
61. Sasaki M, et al. 2005. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis. 11:151-156.
62. Sedgley C, Buck G, Appelbe O. 2006. Prevalence of Enterococcus faecalis at multiple oral sites in endodontic patients using culture and PCR. J. Endod. 32:104-109.
63. Shiga K, et al. 2001. Presence of Streptococcus infection in extraoropharyngeal head and neck squamous cell carcinoma and its implication in carcinogenesis. Oncol. Rep. 8:245-248.
64. Shin DM, Ro JY, Hong WK, Hittelman WN. 1994. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 54:3153-3159.
65. Shintani S, et al. 2004. Gefitinib ('Iressa,' ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines. Oral Oncol. 40:43-51.
66. Skvortsov S, et al. 2008. Cetuximab inhibits thymidylate synthase in colorectal cells expressing epidermal growth factor receptor. Proteomics Clin. Appl. 2:908-914.
67. Souto Damin AP, et al. 2006. Detection of human papillomavirus DNA in squamous cell carcinoma of the esophagus by auto-nested PCR. Dis. Esophagus 19:64-68.
68. Stransky N, et al. 2011. The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157-1160.
69. Stuart CH, Schwartz SA, Beeson TJ, Owatz CB. 2006. Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment. J. Endod. 32:93-98.
70. Van Winkle LS, Isaac JM, Plopper CG. 1997. Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. Am. J. Pathol. 151:443-459.
71. Waar K, Degener JE, van Luyn MJ, Harmsen HJ. 2005. Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples. J. Med. Microbiol. 54:937-944.
72. Wang X, et al. 2008. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res. 68:9909-9917.
73. Wang X, Huycke MM. 2007. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132:551-561.
74. Warnakulasuriya S. 2009. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45:309-316.
75. Wong BC, et al. 2001. Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 15:1459-1465.
76. Zheng JN, et al. 2009. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. Cancer Gene Ther. 16:20-32.